0
Signin
countryflagUS

18889881171

MSFT 430.59 0.8407% AAPL 222.5 -0.1212% NVDA 119.1 -0.0336% GOOGL 157.46 1.7907% GOOG 158.37 1.8195% AMZN 186.49 -0.2727% META 524.62 -0.1865% AVGO 167.69 1.902% TSLA 230.29 0.2089% TSM 172.5 0.6242% LLY 923.71 -1.2096% V 287.35 0.6938% JPM 204.32 -1.1036% UNH 594.32 1.0027% NVO 137.0 0.2488% WMT 80.6 1.18% LVMUY 134.665 -0.226% XOM 111.15 -0.0719% LVMHF 675.14 0.1691% MA 493.36 0.254%

Flora Growth Corp

Healthcare US FLGC

0.968USD
-(-%)

Last update at 2024-09-13T20:00:00Z

Day Range

0.930.98
LowHigh

52 Week Range

0.635.48
LowHigh

Fundamentals

  • Previous Close 0.97
  • Market Cap16.66M
  • Volume49665
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-8.44800M
  • Revenue TTM74.78M
  • Revenue Per Share TTM9.44
  • Gross Profit TTM 2.42M
  • Diluted EPS TTM-6.24

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -54.16700M -21.45900M -14.33400M -
Minority interest 0.21M 0.11M -0.11300M -0.01100M
Net income -52.62900M -21.36100M -14.25900M -
Selling general administrative 24.86M 17.44M 11.85M -
Selling and marketing expenses 8.42M - - -
Gross profit 14.41M 2.42M 0.07M -
Reconciled depreciation 2.63M 0.77M 0.11M -
Ebit 3.29M -19.71600M -12.33600M -3.38280M
Ebitda 5.92M -18.95100M -12.22300M -
Depreciation and amortization 2.63M 0.77M 0.11M -
Non operating income net other - - - -
Operating income 3.29M -18.95100M -12.33600M -
Other operating expenses 62.64M 21.38M 12.50M -
Interest expense 0.06M 0.08M 0.03M 0.00000M
Tax provision -1.53800M -0.09800M - -
Interest income 0.06M - - -
Net interest income 0.06M -0.08400M -0.03000M -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -1.53800M -0.09800M -0.07500M -
Total revenue 37.17M 8.98M 0.11M -
Total operating expenses 39.88M 21.38M 12.47M -
Cost of revenue 22.76M 6.55M 0.04M -
Total other income expense net -57.46000M -2.50800M -1.99800M -
Discontinued operations - - - -
Net income from continuing ops -52.62900M -21.36100M -14.33400M -
Net income applicable to common shares - -21.24900M -14.17000M -3.38880M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 23.63M 80.99M 85.48M 19.45M 1.17M
Intangible assets 0.95M 18.10M 9.74M 0.66M 0.57M
Earning assets - - - - -
Other current assets 1.37M 0.98M 0.04M 0.35M 0.21M
Total liab 17.22M 24.57M 8.54M 3.20M 2.48M
Total stockholder equity 6.40M 56.82M 77.17M 16.36M -1.29442M
Deferred long term liab - - - - -
Other current liab 8.44M 7.42M 0.06M 0.60M 1.15M
Common stock - - 102.43M 27.25M 1.40M
Capital stock 0.00000M 0.00000M 102.43M 27.25M 1.40M
Retained earnings -142.54900M -90.86500M -38.53600M -17.28700M -2.82433M
Other liab - - 1.51M 0.14M -
Good will 0.00000M 23.37M 20.05M 0.43M -
Other assets - - 0.10M - -
Cash 4.38M 9.54M 37.61M 15.52M 0.14M
Cash and equivalents - - - - -
Total current liabilities 16.28M 17.45M 6.12M 2.74M 2.23M
Current deferred revenue - - - - -
Net debt -0.71300M -5.39400M -36.27600M -14.87400M 1.19M
Short term debt 2.73M 2.27M 0.43M 0.33M 1.08M
Short long term debt 1.93M 1.09M 0.02M 0.25M 1.03M
Short long term debt total 3.67M 4.14M 1.34M 0.65M 1.33M
Other stockholder equity 149.09M 150.42M 14.38M 6.36M 0.11M
Property plant equipment - - 4.98M 0.73M 0.43M
Total current assets 21.36M 31.16M 47.94M 17.63M 0.46M
Long term investments 0.00000M 0.73M 2.67M - -
Net tangible assets - - 47.38M 15.27M -1.57100M
Short term investments - -0.72927M - - -
Net receivables 7.10M 10.55M 5.60M 1.22M 0.11M
Long term debt - - - 0.07M -
Inventory 8.51M 10.09M 3.03M 0.54M -
Accounts payable 5.11M 7.75M 5.63M 1.81M 0.33M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.14000M -2.73200M -1.10800M 0.04M 0.02M
Additional paid in capital - - - - -
Common stock total equity - - - 27.25M 1.40M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.08M 0.29M 0.10M - 0.28M
Deferred long term asset charges - - - - -
Non current assets total 2.26M 49.83M 37.54M 1.82M 0.71M
Capital lease obligations 1.74M 3.06M 1.32M 0.33M 0.30M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -15.80200M -2.50900M -2.16400M -2.50900M
Change to liabilities - 3.05M -0.32300M 1.23M
Total cashflows from investing activities - -14.55000M -2.16400M -0.51720M
Net borrowings - -0.51500M -1.07400M 1.21M
Total cash from financing activities 4.41M 58.11M 25.82M 1.21M
Change to operating activities - -1.25500M -0.02600M -0.20400M
Net income -52.62900M -21.36100M -14.33400M -3.38880M
Change in cash -28.07900M 22.09M 15.38M 0.17M
Begin period cash flow 37.62M 15.52M 0.14M -
End period cash flow 9.54M 37.61M 15.52M 0.14M
Total cash from operating activities -15.93500M -20.64800M -8.42100M -0.54480M
Issuance of capital stock 4.55M 42.62M 30.00M -
Depreciation 2.63M 0.77M 0.11M 0.03M
Other cashflows from investing activities - - - -
Dividends paid - 2.51M 0.00000M -
Change to inventory 1.22M -1.14100M -0.05500M -0.05500M
Change to account receivables - -5.68800M -0.54300M -0.02280M
Sale purchase of stock -0.25500M 2.51M - -
Other cashflows from financing activities 0.31M 16.00M -3.10400M 1.25M
Change to netincome - 4.87M 6.58M 1.81M
Capital expenditures 1.29M 3.98M 0.23M 0.17M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 3.82M -5.03700M -0.94700M -
Stock based compensation 3.40M 1.34M 4.90M -
Other non cash items 28.38M 3.74M 0.03M -
Free cash flow -17.22900M -24.63100M -8.65500M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
FLGC
Flora Growth Corp		 - -% 0.97 - 72.46 0.28 3.35 0.27 -0.4537
ZTS
Zoetis Inc		 0.38 0.20% 191.09 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.17 0.45% 37.27 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 8.28 4.48% 193.00 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.12 0.81% 14.70 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Flora Growth Corp

3406 SW 26th Terrace, Fort Lauderdale, FL, United States, 33132

Key Executives

Name Title Year Born
Mr. Luis Merchan Pres, CEO & Chairman 1981
Dr. Bernard Raymond Wilson F.C.A., FCA, FCPA, ICD.D, LLD(H) Advisor 1943
Mr. Elshad Garayev CPA, CPA Chief Financial Officer NA
Mr. Matthew S. Cohen Gen. Counsel 1966
Ms. Jessie Casner Chief Marketing Officer 1988
Mr. James Choe Chief Strategy Officer 1979
Mr. Aaron Atin Corp. Sec. 1984
Mr. Javier Franco VP Agriculture 1968
Ms. Holly Bell VP of Regulatory Affairs NA
Mr. Clifford A. Starke CEO & Director 1985

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.